Driehaus Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,000,000
Closed -$9.8M – 466
2021
Q4
$9.8M Hold
1,000,000
– – 0.1% 242
2021
Q3
$9.8M Buy
+1,000,000
New +$9.9M 0.12% 238

Other funds holding DALS

Driehaus Capital Management's DALS Position: Q1 2022 in Review

Driehaus Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2022, closing a stake of 1,000,000 shares — an estimated $9.8M sold.

Driehaus Capital Management first reported a position in DALS in Q3 2021 and held it in 2 quarters. The position peaked at $9.8M in Q3 2021. 44 funds tracked by Wall St. Rank hold DALS as of Q1 2022.

  • Driehaus Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 1,000,000 DA32 Life Science Tech Acquisition Corp shares in Q1 2022, an estimated $9.8M.
  • Driehaus Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 2 quarters.
  • Driehaus Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $9.8M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2022.

Based on Driehaus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.